Autoimmune symptoms of (NZB×NZW )F1 (H-2d/z) mice are reported to be critically related to the heterozygosity at the H-2 complex of the murine major histocompatibility complex (MHC ). We previously showed that several Abz/Aad MHC class II molecule-restricted autoreactive T-cell clones from B/WF1 mice were pathogenic upon transfer to preautoimmune B/WF1 mice. In this study, to identify the crucial amino acid residues in Abz/Aad molecules for T-cell activation, we generated a panel of transfectant cell lines. These transfectant cell lines express the Abz/Aad MHC molecules with a mutation at each residue a11, a28, a57, a69, a70, a76 of Aad chain and b86 of Abz chain. Replacing a69 alanine with threonine, valine or serine completely eliminated the ability to stimulate autoreactive T-cell clones without affecting the ability to present foreign antigen keyhole limpet haemocyanin ( KLH ) or -plastin peptide to specific T-cell clones. Replacing b86 valine with aspartic acid resulted in a decrease in the stimulation for antigen-reactive as well as autoreactive T-cell clones. Substitutions at other residues had minimal or no effect on the stimulation of either auto-or antigen-reactive T-cell clones. These results suggest that alanine at residue 69 of the Aad chain is critical for the activation of autoreactive Abz/Aad-restricted T-cell clones. Possible explanations for this are discussed.
INTRODUCTION
ted by such Abz/Aad molecules. 10 Further studies demonstrated that some of these autoreactive T-cell clones induced anti-(NZB×NZW )F1 (B/WF1) mice have been studied as an DNA antibody of IgG class in cell transfer experiments.11 animal model for human systemic lupus erythematosus (SLE) These studies suggested that the recognition of self-peptide(s) (reviewed in 1-3). At around 6 months of age, these mice in association with Abz/Aad class II molecules by pathogenic start to show elevated serum immunoglobulin G (IgG) antiautoreactive T cells is important for the onset and/or pro-DNA antibodies and severe immune-complex glomerulogression of B/WF1 autoimmunity. In an accompanying paper, nephritis. Female mice are more susceptible to autoimmune we examined the characteristics of peptides that bind to symptoms than are male mice. In addition to the abnormality Abz/Aad class II molecules12 and suggested that charged in both B and T lymphocytes,4-7 classic genetic studies revealed residues in the peptide sequence affect the binding to the that the heterozygosity at the H-2 complex of the murine Abz/Aad molecules. major histocompatibility complex (MHC ) is critically involved
In this study, we attempted to clarify whether unique in the development of B/WF1 autoimmunity.8, 9 amino acid residue(s) in the Abz/Aad class II molecules might Our previous studies demonstrated the existence of mixed exist which are crucial for the activation of autoreactive T cells. haplotype Abz/Aad major histocompatibility complex (MHC )
We generated and analysed a panel of transfectant cell lines class II molecules on B/WF1 spleen cells and the existence of that express Abz/Aad molecules with single amino acid substiautoreactive and foreign antigen-reactive T-cell clones restrictutions at several polymorphic sites on the a or b chain. Our results suggest that alanine at position 69 of the Aad chain is (Shizuoka, Japan). (NZB×NZW )F1 (B/WF1) mice were the site of the wildtype amino acid to the expected mutant amino acid residues by single-letter codes of amino acid. Most generated by mating female NZB with male NZW mice in our animal breeding facilities. Animals in this study were used in of these mutagenic oligonucleotides or PCR primers were designed to introduce or destroy a restriction enzyme site in accordance with the Saga Medical School Guidelines for Animal Experimentation. their sequences, as described in into pCEXV vector.22 according to the manufacturer's protocol. The sequence was confirmed by automated Edman degradation using a pulsed DNA transfection For Aad cDNA transfection, 2×107 class II negative 2C3 liquid protein sequencer 477A equipped with an on-line phenylthiohydantoin (PTH ) amino acid analyser 120A (Applied cells15 were cotransfected with 20 mg of pCEXVAad cDNA and 1 mg of pSV2-hyg plasmid (kindly provided by Dr Itoh, Biosystem, Foster City, OR), and the purity was more than 95% by reversed phase high pressure liquid chromatography Saga Medical School, Japan) by electroporation. The electroporation was performed three times at 1·0 kV/cm with a capaci-(HPLC ) analysis. The origins and specificities of anti-class II mAb hybridoma cell lines 10.2.16 (anti-Abk, cross-react to tance of 25 mF using a Gene-Pulser (Bio-Rad Laboratories, Richmond, CA). 48 hr after transfection, a selection medium Abz),13 K24-199 (anti-Aad)14 and BW/9 (rat anti-mouse monomorphic I-A mAb)15 are described in each reference.
containing 300 mg/ml hygromycin ( Wako Chemical, Osaka, Japan) was added to the culture. After 2-3 weeks, hygromycin Culture supernatants of hybridoma cell lines and appropriately diluted ascitic fluids were used for immunofluorescence resistant clones were stained with anti-class II mAb (BW/9 One million cells were first incubated with 100 ml of appropriately diluted mAbs for 30 min at 4°. Cells were washed three of the a and b chains of class II molecules. The establishment of T-cell lines and clones has been previously described. 10, 11 times with HBSS containing 1% fetal calf serum (FCS) and 0·1% NaN 3 (staining buffer). Then, 20 ml of appropriately Clones used in this paper were derived from B/WF1 mice. KGU140 and AU3-16 T-cell clones are autoreactive. KLH58 diluted fluoroscein isothiocyanate (FITC )-protein A (Zymed Lab. Inc., San Francisco, CA) or FITC-Mar 18.5 (mouse is a KLH-specific T-cell clone. LP207, LP824 and LP10-3 T-cell clones are specific for -plastin 588-605 peptide.17 All anti-rat k chain mAb)23 was added and the mixture was incubated for 30 min at 4°. This was followed by addition of of the clones have Abz/Aad-restriction specificity. cDNA sequencing of the a and b chain of the TCR of these T-cell 10 ml of 50 mg/ml propidium iodide (Sigma, St. Louis, MO) for the final 5 min to gate out dead cells. Cells were then clones was performed18,19 and the deduced amino acid sequences are described in Table 1. washed three times with cold staining buffer and analysed by fluorescence-activated cell sorting (FACScanB; BectonDickinson Immunocytometry Systems, Mountain View, CA).
Site-directed mutagenesis
Site-directed mutagenesis of Aad or Abz cDNA was performed
The quantitative immunofluorescence analysis was performed as described by Braunstein and Germain24 with slight modifiusing an Altered Sites II in vitro Mutagenesis System (Promega, Madison, WI ) or using a polymerase chain reaction (PCR) cations. Briefly, 3×105 transfectant cells in 100 ml staining buffer were stained with 100 ml of a serial dilution of the mutagenesis.21 Mutagenic oligonucleotides and PCR primers were purchased from Bio-Synthesis, Inc. (Lewisville, TX ) and K24-199 mAb followed by FITC-protein A. Cells were analysed on a FACScan and the mean fluorescence intensity are listed in Table 2 . These mutagenic oligonucleotides or primers were named according to their target positions and (MFI ) was calculated. 
Diagnostic restriction enzyme sites are underlined. Mismatches with the template are indicated by lowercase letters. The names of the oligonucleotides or primers indicate the target position and the wildtype amino acid to the expected mutant amino acid residues by single-letter codes.
*(+) Introduced enzyme site. †(−) Destroyed enzyme site.
Peptide binding assay T-cell stimulation assay
Complete medium consists of RPMI-1640 culture medium This was performed according to Malcherek et al.25 with slight modification.12 Briefly, a saturating concentration of 100 m (Gibco BRL) containing 10% heat-inactivated fetal calf serum (Intergen, Purchase, NY ), 5×10−5  2-mercaptoethanol, N-terminally biotinylated -plastin 588-605 peptide was incubated with 5×104 wildtype or mutant transfectant cell lines 10 m HEPES (Gibco BRL), 100 U/ml penicillin and 100 mg/ml streptomycin. -glutamine was added at a final in 200 ml culture medium and the mixture was incubated at 37°for 20 hr in a microtitre plate (Falcon no. 3075, Bectonconcentration of 2×10−3  before use. Cytokine release of T-cell clones was assayed as described.11,15 Thus, 1×104 T-cell Dickinson, Lincoln, NJ ). The cells were then washed and incubated with FITC-streptavidin (Gibco BRL, Rockville, clones and the indicated number of transfectant cells were cultured with or without the appropriate antigens in 0·2 ml MD) at 4°. Propidium iodide was added for the final 5 min to gate out dead cells. Stained cells were analysed on a FACScan.
complete medium in a 96-well culture plate (Falcon no. 3075). After 24 hr, 0·1 ml supernatant was transferred to wells conThe peptide binding assay was repeated three times with reproducible results.
taining 1×104 CT-6 cells (an IL-2 and IL-4 cytokine dependent cell line)26 in 0·1 ml complete medium. 
RESULTS

Expression of mutant Abz/Aad class II molecules in B lymphoma cells
We selected polymorphic sites in the Aa and Ab chain of class II molecules for the target sites of mutagenesis because polymorphic sites in the MHC molecules were shown to be critical for the binding of antigenic peptides (reviewed in 27). Almost all the mutageneses were arbitrarily designed to change from the wildtype to one of the parental (d or z haplotype) amino acid residues. For residue 69 in the Aad chain, the mutagenesis was also designed to change to representative amino acids in the hydrophobic or hydrophilic side chain group. Each mutated Aad or Abz cDNA was transfected together with a hygromycin-resistance gene or a neomycin-resistance gene into the class II mutant B lymphoma line 2C3 cells or M12.C3 cells, respectively. After selection, stable transfectant cell lines were analysed for their expression of class II molecules by staining with monomorphic anti-class II mAb (BW/9). We selected transfectant cell lines of the highest class II molecule expression out of several independent clones of each mutant for analysis in this study. As shown in Fig. 1 , most of the We examined the ability of these transfectant cell lines to stimulate Abz/Aad-restricted autoreactive and antigen-reactive wildtype or mutant Abz/Aad molecules are expressed on the cell surface.
T-cell clones. Proliferative responses of T-cell clones against each transfectant APC line were performed in one set of In spite of multiple transfection experiments, we were not able to obtain transfectant cell lines with mutations at residues experiments to compare the stimulatory activity of each mutation. Because the amounts of Abz/Aad class II molecules b11 and b13 of the Abz chain. This was not due to inefficient transfection because we were able to demonstrate the existence on transfectant cells vary for each line, we first assessed whether the amounts of class II molecules affect the stimulatory of b11F-L and b13P-M mutant transcripts in transfectant cell lines by RT-PCR. We speculate that a reason for the lack of activity on T-cell clones. As shown in Fig. 2 , wildtype transfectant cell lines that express various amounts of Abz/Aad expression could be that the mutation at b11 or b13 results in defects in pairing ability to the a chain. The importance for ( TAbz-H, TAbz-I, TAbz-L) showed a similar degree of stimulation against all the T-cell clones. This indicates that the the N-terminal residues in pairing a and b chains of class II molecules was already suggested.24 amounts of Abz/Aad molecules do not significantly affect this assay within the range of amounts that are expressed in Conformation of mutant Abz/Aad molecules on transfectant cell lines examined by mAbs wildtype TAbz-H to TAbz-L cells.
As shown in Fig. 2 , the substitution of wildtype alanine at One explanation for the loss of or decreased stimulatory position 69 of the Aad chain into threonine (z haplotype) activity of a69 and b86 mutant APC lines is that these resulted in the complete loss of stimulatory activity to two mutations resulted in gross conformational changes in the different autoreactive T-cell clones. However, this substitution structure of Abz/Aad class II molecules. To examine this, we did not affect the stimulatory activity against any of the performed quantitative immunofluorescence analysis that antigen-specific T-cell clones examined. Furthermore, substiallows evaluation of relative affinity of the antibody binding24 tution of alanine at a69 into valine (hydrophobic) or serine and thus reflects the conformational change of class II mol-(hydrophilic) also eliminated the stimulatory activity against ecules by mutagenesis. As shown in Fig. 3(a) , a69A-T and autoreactive T-cell clones. Surprisingly, these mutations did a69A-S mutant APC lines showed decreased affinity to antinot affect the stimulatory activities against all four independent Aad ( K24-199) mAb compared to the wildtype TAbz cells. antigen-reactive T-cell clones examined. Because the mutation
The data of a69A-V mutant APC lines was difficult to interpret at a69 affected only the autoreactive but not the antigenbecause of the weak intensity of staining. These results indicate that the mutation at position 69 of the Aa chain induced slight reactive T-cell clones, alanine at this position in the Abz/Aad conformational changes in the Abz/Aad molecules. Although molecules may have critical influences on the stimulation of weak in staining intensity of the b86V-D mutant cell line, it autoreactive T-cell clones. It should be noted that these two showed increased affinity to anti-Aad mAb staining, indicating autoreactive T-cell clones have different T-cell receptor (TCR) that this mutation also resulted in a slight conformational a and b chains ( Table 1) .
change of Abz/Aad molecules. Mutations at other positions Substitution of valine at position 86 of the Abz chain into did not show significant changes in affinity to anti-Aad aspartic acid resulted in a decrease of stimulatory activity ( K24-199) mAb (Fig. 3b) and may not have caused conforagainst almost all the antigen-and autoreactive T-cell clones.
mational changes in these class II molecules. This would be caused by the very low expression of class II molecules on b86V-D mutant cell lines (Fig. 1) 
and TAbz-L (···2···) transfectant cell lines is also shown.
a naturally eluted peptide from purified Abz/Aad class mutant), -plastin 588-605 peptide binding studies did not show a substantial difference between mutant and wildtype II molecules and synthetic -plastin 588-605 peptide (SMARKIGARVYALPEDLV ) bind to Abz/Aad.12 Abz/Aad lines (Fig. 4) . Also, the observation that antigenreactive T-cell clones showed a similar degree of proliferation Transfectant cell lines with wildtype or mutant Abz/Aad molecules were incubated with biotinylated -plastin 588-605 against a69 mutant and wildtype APCs supports the idea that gross conformational changes are unlikely. peptide followed by FITC-streptavidin and analysed by FACScan. Because each transfectant cell line expressed differOne explanation for the effect of a69 mutations would be that the peptides recognized by autoreactive T-cell clones have ent amounts of Abz/Aad molecules, the efficiency of peptide binding was expressed as the percentage relative peptide bindspecific affinity to the structure created by alanine at a69. A conservative change of alanine to hydrophobic residue valine ing as described in the legend to Fig. 4 . The peptide binding was specific for all the transfectant cell lines because the or a non-conservative changes to hydrophilic residue serine or threonine resulted in the complete loss of stimulation against Abz/Aad negative parental APC line (M12.C3) did not bind the peptide.12 Also the anti-Abz mAb (10.2.16) partially autoreactive T-cell clones. This may indicate that alanine, by itself or in combination with other surrounding residues blocked the peptide binding to each transfectant (data not shown). As shown in Fig. 4 , almost all transfectant cell lines around a69, is critical for binding to the target peptides. The small side chain of alanine could exert this effect. Attempts to with wildtype or mutant Abz/Aad molecules showed similar binding ability to this peptide except a69 A-T mutant cell substitute alanine by the smaller glycine at a69 were unsuccessful in achieving its expression, probably due to the conforlines. The a69A-T mutation appears to affect the peptide binding to Abz/Aad molecules. Although the results show mational unstability of the mutated polypeptide chain. Because two independent T-cell clones with different TCR some variability, especially when class II expression is low, other mutant APC lines in this study may not have altered sequences and, therefore, two different target peptides, were affected in a similar way, these peptides may have common Abz/Aad conformation for peptide binding.
features for the binding to Abz/Aad and, specifically, to the structure around position a69. It is interesting to note here DISCUSSION that our accompanying paper12 showed that the side chain of binding peptide at relative position 6 (p6) influenced the The most interesting finding in this study is that substitution of alanine to threonine, valine or serine at position 69 in the peptide binding and that residues with large and negatively charged side chains are not tolerated at p6. The position of Aad chain of Abz/Aad class II molecules resulted in the complete loss of stimulatory activity against Abz/Aad-restricted a69 corresponds to pocket 6 in the class II molecule that accommodates the side chain of residue at relative position 6 autoreactive T-cell clones. The mutations affected two independent autoreactive T-cell clones with different TCR a and b of the binding peptide, as speculated by the crystallographic analysis of class II molecules.35,36 chains. The a69 mutations, however, did not show a significant effect on the stimulatory activity against antigen-reactive Another explanation for the loss of stimulatory activity of a69 mutant APCs against auto-but not antigen-reactive T-cell Abz/Aad-restricted T-cell clones. The reason for the complete loss of stimulatory activity of a69 mutant APCs was probably clones is that the responsiveness of these autoreactive T-cell clones, and potentially the autoreactive T-cell clones in general, not a result of the gross conformational alterations of the Abz/Aad molecules by the mutagenesis, as (i) immunofluoresis sensitive to the slight structural change of class II molecules.
As shown in the quantitative immunofluorescence experiments cence staining by haplotype specific anti-class II mAbs did not show loss of staining and, (ii) with one exception (the a69A-T (Fig. 3) , substitution of alanine at a69 to other residues tion for almost all the T-cell clones examined irrespective of their antigen-specificity. The reason for this could be a marked decrease in the expression of MHC molecules on the cell surface (Fig. 1) . Quantitative immunofluorescence analysis indicated a mutation-induced change of mAb binding affinity, also suggesting the conformational change of Abz/Aad molecules. Although we were not able to demonstrate a change in peptide binding ability, these findings are essentially consistent with the results reported by several investigators. Substitution of the residue at b86 resulted in very low levels of cell surface expression of class II molecules,31 decreased peptide binding33,34 and weakened T-cell recognition.32-34 Our previous report suggested that mixed haplotype Abz/Aad class II molecules play important roles in the pathogenicity of autoimmunity in B/WF1 mice.11 It would be interesting to examine whether in vivo expression of mutated Abz/Aad class II molecules at position 69 in the a chain can prevent the onset and/or progression of autoimmune symptoms of B/WF1 mice. It is also interesting that autoreactive T cells in general are sensitive to mutation at position 69 in the a chain, irrespective of the haplotype specificity.
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